Literature DB >> 18402825

Ascending aortic aneurysms in unicommissural aortic valve disease.

Jagdish Butany1, Pradeep Vaideeswar, Vidya Dixit, Vidyadhar Lad, Annette Vegas, Tirone E David.   

Abstract

BACKGROUND: Aneurysms of the ascending aorta occur as result of intrinsic changes in the aortic wall and have been well documented in patients with bicuspid aortic valve (BAV). In few reported clinical studies, documenting aneurysmal dilatation in unicommissural aortic valves (UAV); there have been no comments on the aortic wall pathology. This study presents the pathological findings of the ascending aorta in patients with UAV.
MATERIALS AND METHODS: The clinical data from 39 patients with concomitant excision of the UAV and aneurysmal aortic tissue were reviewed. In all cases, the gross features of the valve and aortic segments were noted and submitted for histology. The sections of the aorta were semi-quantitatively graded for the extent of medionecrosis, cystic medial change, fibrosis, and elastic tissue changes (fragmentation/ loss) in the media. The medial alterations were correlated with patient age, gender, and valvular dysfunction, and compared to aneurysmal disease in BAV and three-cuspid aortic valves (TAV) excised over a 3-year period.
RESULTS: Among 39 patients studied, a majority were males (92.3%), with a mean age at surgery of 39.92 years. Only three patients (7.69%) were above the age of 50 years. Eighteen patients (46.1%) had aortic stenosis with regurgitation. Ascending aorta diameters ranged from 4 to 5.5 cm. The overall pattern of medial changes was nearly the same in all cases of UAV, irrespective of age and nature of valvular dysfunction. Most cases showed mild histological changes, with medionecrosis and fibrosis being the more common and consistent features. However, varying grades of change affected different portions of the media and/or the aortic wall in the same patient. The changes in UAV aortae were comparable to the changes seen in the TAV and BAV, but these differed with the age of onset.
CONCLUSIONS: This study demonstrates the presence of medial changes in the ascending aortic tissue in all patients of UAV with aneurysms. These changes, while mild to moderate in degree, likely have a similar pathogenetic mechanism as those seen in BAV disease. The significant difference in age, at the time of surgery, suggests a more rapid progression of the aortic changes.

Entities:  

Mesh:

Year:  2008        PMID: 18402825     DOI: 10.1016/j.carpath.2007.12.004

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  5 in total

1.  Incidental diagnosis of the unicuspid aortic valve with ascending aortic aneurysm in an asymptomatic adult.

Authors:  Seung-Dae Kang; Sang-Hoon Seol; Bo-Min Park; Dong-Kie Kim; Ki-Hun Kim; Doo-Il Kim; Jeong-Sook Seo; Dong-Soo Kim; Hyun-Kuk Kim; Jong-Woon Song
Journal:  J Cardiovasc Ultrasound       Date:  2011-06-30

2.  Outcomes After Operations for Unicuspid Aortic Valve With or Without Ascending Repair in Adults.

Authors:  Yuanjia Zhu; Eric E Roselli; Jay J Idrees; Charles M Wojnarski; Brian Griffin; Vidyasagar Kalahasti; Gosta Pettersson; Lars G Svensson
Journal:  Ann Thorac Surg       Date:  2015-10-09       Impact factor: 4.330

3.  Symptomatic unicuspid aortic valve.

Authors:  Gohar Jamil; Walaa Said Dabbas; Mahmuneer Khan; Mujgan Jamil
Journal:  BMJ Case Rep       Date:  2015-12-17

4.  Identification of Reference Genes for Quantitative Real Time PCR Assays in Aortic Tissue of Syrian Hamsters with Bicuspid Aortic Valve.

Authors:  Carmen Rueda-Martínez; M Carmen Fernández; María Teresa Soto-Navarrete; Manuel Jiménez-Navarro; Ana Carmen Durán; Borja Fernández
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

5.  Endothelial nitric oxide synthase alterations are independent of turbulence in the aorta of patients with a unicuspid aortic valve.

Authors:  Brittany Balint; Catherine Kollmann; Simon Gauer; Jan M Federspiel; Hans-Joachim Schäfers
Journal:  JTCVS Open       Date:  2021-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.